CSI Market
Sign In | Register

Universe Pharmaceuticals Inc (UPC) Annual Balance Sheets

Annual · GAAP · USD millions
Access UPC quarterly Balance Sheets →
Examining balance sheet movements between Universe Pharmaceuticals Inc and Sep 30 2021 reveals how Sep 30 2025 adjusts its asset composition and liability profile.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Annual Report, GAAP in USD millions
ITEM 		(Sep 30 2025)
(Sep 30 2024) (Sep 30 2023) (Sep 30 2022) (Sep 30 2021)
Assets
Cash & cash equivalent33,592.03
Short-term Investments, Total0.00
Other Short-term Investments0.00
Cash & Short-term Investments33,592.00
Accounts receivable13,026.33
Other Receivables2,280.68
Notes Receivable, Current1,023.08
Inventories1,608.49
Derivatives, Collateral, Regulatory, Deferred0.00
Other Current Assets2,489.74
Total loans net177.90
Total Current Assets53,603.68
Equipment/Property/Plant Net6,903.75
Intangible Assets177.15
Long-term investments702.35
Tax Assets, Noncurrent2,167.16
Prepaid Expense and Other Assets, Total3.40
Other Assets, Noncurrent11,819.43
Advance To Suppliers Net-
Prepayment For Advertising-
Prepayment For Acquisition Current-
Prepayments Made To A Related Party For Purchase Of Property Non Current-
Prepayments For Construction In Progress8,869.57
Investment In Equity Securities-
Deferred Income Tax Assets Net-
Total Assets69,303.44
Liabilities
Accounts Payable, Current AC262.62
Accrued Liabilities And Other Liabilities0.00
Short-term Debt DE12,107.04
Other Liabilities, Current3,713.48
Taxes Payable, Current, Total640.78
Total Current Liabilities13,173.93
Long-term debt0.00
Total Long-term Debt0.00
Other liabilities, Noncurrent0.00
Contract With Customer Liability Current40.71
Other Payable856.57
Total Liabilities13,173.93
Stockholders' Equity
Statutory Reserve2,439.54
Common Stock Value6,337.55
Additional Paid In Capital Common Stock63,009.57
Retained Earnings / Accumulated Deficit-13,843.62
Accumulated Other Comprehensive Income-1,813.52
Other Equity-1,813.52
Common Stockholder's Equity56,129.51
Total Stockholder's Equity56,129.51
Liabilities & Stockholder's Equity69,303.44
4 historic quarters locked

Sign in to unlock the full Universe Pharmaceuticals Inc balance sheet history.

Sign In Create Free Account

About Universe Pharmaceuticals Inc Annual Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 20-F filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001213900-26-009000

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.